Andrew Brooks

Andrew I. Brooks
Andrew I. Brooks
Born	February 10, 1969; Bronxville, New York, U.S.
Died	January 23, 2021 (aged 51); New York City, U.S.
Education	University of Rochester School of Medicine (PhD);
Known for	First FDA approved COVID-19 saliva-based/home-use test;
Spouse	Jill Brooks
Children	3
	Scientific career
Fields	Molecular neuroscience
Institutions	University of Medicine and Dentistry of New Jersey; RUCDR Infinite Biologics;

Andrew Ira Brooks (February 10, 1969 – January 23, 2021) was an American immunologist, academic, and businessman. He was an associate research professor at Rutgers University. He created the first FDA-approved rapid saliva test for COVID-19 diagnosis.[1]

Brooks died on January 23, 2021 from a heart attack in New York City, aged 51.[2]

References

Buccino, Neal (January 26, 2021). "Mourning the Death of Rutgers' Andrew Brooks, a Leader in the Fight Against COVID-19". Rutgers.edu. Archived from the original on January 26, 2021. Retrieved February 1, 2021.
Snyder, Alec (January 31, 2021). "Andrew Brooks, who led development of the first FDA-approved Covid-19 saliva test, dies at 51". CNN. Archived from the original on February 1, 2021. Retrieved February 1, 2021.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[Rutgers-obit-1] Buccino, Neal (January 26, 2021). "Mourning the Death of Rutgers' Andrew Brooks, a Leader in the Fight Against COVID-19". Rutgers.edu. Archived from the original on January 26, 2021. Retrieved February 1, 2021.

[2] Snyder, Alec (January 31, 2021). "Andrew Brooks, who led development of the first FDA-approved Covid-19 saliva test, dies at 51". CNN. Archived from the original on February 1, 2021. Retrieved February 1, 2021.